{"lastClose": 39.2599983215332, "len": 227, "date": "2022-12-01", "alpha_3mo": 2.358699896144458, "beta_3mo": 0.8886632760776619, "drawup_3mo": 0.45246013038135335, "sharpe_3mo": 3.2660157474188094, "natr_3mo": 5.5783547109161935, "sup_3mo": -0.030055980960067046, "res_3mo": 0.056036732770275426, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 64.80489729063011, "adx_3mo": 31.913901127492977, "drawdown_3mo": -0.13387905565942637, "IPO Year": 2022.0, "Market Cap": 2583661221, "Name": "Amylyx Pharmaceuticals Inc.", "Country": "United States", "Sector": "Health Care", "Industry": "Biotechnology: Pharmaceutical Preparations", "alpha%_3mo": 0.9832709689500971, "beta%_3mo": 0.4528764473829165, "drawup%_3mo": 0.8816826747274564, "sharpe%_3mo": 0.9199609420307719, "natr%_3mo": 0.7362403111325383, "drawdown%_3mo": 0.7007135074812313}